These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 27491309)

  • 1. Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects.
    Nagatsu T; Nagatsu I
    J Neural Transm (Vienna); 2016 Nov; 123(11):1255-1278. PubMed ID: 27491309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catecholamines and Parkinson's disease: tyrosine hydroxylase (TH) over tetrahydrobiopterin (BH4) and GTP cyclohydrolase I (GCH1) to cytokines, neuromelanin, and gene therapy: a historical overview.
    Nagatsu T
    J Neural Transm (Vienna); 2024 Jun; 131(6):617-630. PubMed ID: 37638996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemistry of postmortem brains in Parkinson's disease: historical overview and future prospects.
    Nagatsu T; Sawada M
    J Neural Transm Suppl; 2007; (72):113-20. PubMed ID: 17982884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease.
    Shen Y; Muramatsu SI; Ikeguchi K; Fujimoto KI; Fan DS; Ogawa M; Mizukami H; Urabe M; Kume A; Nagatsu I; Urano F; Suzuki T; Ichinose H; Nagatsu T; Monahan J; Nakano I; Ozawa K
    Hum Gene Ther; 2000 Jul; 11(11):1509-19. PubMed ID: 10945765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human tyrosine hydroxylase in Parkinson's disease and in related disorders.
    Nagatsu T; Nakashima A; Ichinose H; Kobayashi K
    J Neural Transm (Vienna); 2019 Apr; 126(4):397-409. PubMed ID: 29995172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of N-terminus of tyrosine hydroxylase in the biosynthesis of catecholamines.
    Nakashima A; Hayashi N; Kaneko YS; Mori K; Sabban EL; Nagatsu T; Ota A
    J Neural Transm (Vienna); 2009 Nov; 116(11):1355-62. PubMed ID: 19396395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GCH1 Deficiency Activates Brain Innate Immune Response and Impairs Tyrosine Hydroxylase Homeostasis.
    Larbalestier H; Keatinge M; Watson L; White E; Gowda S; Wei W; Koler K; Semenova SA; Elkin AM; Rimmer N; Sweeney ST; Mazzolini J; Sieger D; Hide W; McDearmid J; Panula P; MacDonald RB; Bandmann O
    J Neurosci; 2022 Jan; 42(4):702-716. PubMed ID: 34876467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genes for human catecholamine-synthesizing enzymes.
    Nagatsu T
    Neurosci Res; 1991 Oct; 12(2):315-45. PubMed ID: 1684650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexpression of tyrosine hydroxylase, GTP cyclohydrolase I, aromatic amino acid decarboxylase, and vesicular monoamine transporter 2 from a helper virus-free herpes simplex virus type 1 vector supports high-level, long-term biochemical and behavioral correction of a rat model of Parkinson's disease.
    Sun M; Kong L; Wang X; Holmes C; Gao Q; Zhang GR; Pfeilschifter J; Goldstein DS; Geller AI
    Hum Gene Ther; 2004 Dec; 15(12):1177-96. PubMed ID: 15684695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GTP cyclohydrolase I gene, tetrahydrobiopterin, and tyrosine hydroxylase gene: their relations to dystonia and parkinsonism.
    Nagatsu T; Ichinose H
    Neurochem Res; 1996 Feb; 21(2):245-50. PubMed ID: 9182249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and pharmacological correction of aberrant dopamine synthesis using patient iPSCs with BH4 metabolism disorders.
    Ishikawa T; Imamura K; Kondo T; Koshiba Y; Hara S; Ichinose H; Furujo M; Kinoshita M; Oeda T; Takahashi J; Takahashi R; Inoue H
    Hum Mol Genet; 2016 Dec; 25(23):5188-5197. PubMed ID: 27798097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo L-DOPA production by genetically modified primary rat fibroblast or 9L gliosarcoma cell grafts via coexpression of GTPcyclohydrolase I with tyrosine hydroxylase.
    Leff SE; Rendahl KG; Spratt SK; Kang UJ; Mandel RJ
    Exp Neurol; 1998 Jun; 151(2):249-64. PubMed ID: 9628761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of tyrosine hydroxylase in management of Parkinson's disease.
    Feve AP
    CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):450-5. PubMed ID: 22583428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and assessment of double genes of tyrosine hydroxylase gene and aromatic L-amino acid decarboxylase gene in vitro].
    Su Y; Duan CL; Zhao CL; Zhao HY; Xu QY; Yang H
    Sheng Li Xue Bao; 2003 Oct; 55(5):583-8. PubMed ID: 14566408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catecholamine-related enzymes and the biopterin cofactor in Parkinson's disease and related extrapyramidal diseases.
    Nagatsu T; Yamaguchi T; Rahman MK; Trocewicz J; Oka K; Hirata Y; Nagatsu I; Narabayashi H; Kondo T; Iizuka R
    Adv Neurol; 1984; 40():467-73. PubMed ID: 6141712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The catecholamine system in health and disease -Relation to tyrosine 3-monooxygenase and other catecholamine-synthesizing enzymes.
    Nagatsu T
    Proc Jpn Acad Ser B Phys Biol Sci; 2007 Jan; 82(10):388-415. PubMed ID: 25792770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dopa-responsive dystonia: clinical, genetic, and biochemical studies].
    Furukawa Y
    Rinsho Shinkeigaku; 2006 Jan; 46(1):19-34. PubMed ID: 16541791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral recovery in a primate model of Parkinson's disease by triple transduction of striatal cells with adeno-associated viral vectors expressing dopamine-synthesizing enzymes.
    Muramatsu S; Fujimoto K; Ikeguchi K; Shizuma N; Kawasaki K; Ono F; Shen Y; Wang L; Mizukami H; Kume A; Matsumura M; Nagatsu I; Urano F; Ichinose H; Nagatsu T; Terao K; Nakano I; Ozawa K
    Hum Gene Ther; 2002 Feb; 13(3):345-54. PubMed ID: 11860702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of tyrosine hydroxylase in Parkinson's disease.
    Zhu Y; Zhang J; Zeng Y
    CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):350-8. PubMed ID: 22483316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine or biopterin deficiency potentiates phosphorylation at (40)Ser and ubiquitination of tyrosine hydroxylase to be degraded by the ubiquitin proteasome system.
    Kawahata I; Ohtaku S; Tomioka Y; Ichinose H; Yamakuni T
    Biochem Biophys Res Commun; 2015 Sep; 465(1):53-8. PubMed ID: 26225746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.